Atypical Kawasaki disease with peripheral gangrene and myocardial infarction: Therapeutic implications |
| |
Authors: | M. von Planta M. Fasnacht C. Holm S. Fanconi R. A. Seger |
| |
Affiliation: | (1) Division of Immunology/Haematology, University Children's Hospital Zürich, Steinwiesstrasse 75, CH-8032 Zürich, Switzerland;(2) Division of Cardiology, University Children's Hospital, Zürich, Switzerland;(3) Intensive Care Unit, University Children's Hospital, Zürich, Switzerland |
| |
Abstract: | We describe a 2-month-old girl with atypical Kawasaki disease (KD) complicated by peripheral gangrene and myocardial infarction. Peripheral ischaemia leading to gangrene is a rare but serious complication of KD in infants younger than 7 months of age. Treatment has been targeted at reducing arterial inflammation, arteriospasm and thrombosis. We report the first patient with incomplete KD and peripheral ischaemia in whom therapy with prostaglandin E1 (PGE1) as vasodilating and antithrombotic agent appeared successful, restoring hand and foot perfusion without significant long-term sequelae. However, PGE1 could have supported development of myocardial infarction by shunting blood away from ischaemic areas distal to a giant coronary artery aneurysm with beginning thrombosis.Conclusion Atypical KD with peripheral gangrene appears to react favourably to treatment with PGE1, but needs careful monitoring to detect early signs of cardiac ischaemia. |
| |
Keywords: | Atypical Kawasaki disease Giant coronary aneurysm Myocardial infarction Peripheral gangrene Prostaglandin E1 |
本文献已被 SpringerLink 等数据库收录! |
|